Skip to main content
Edwards Lifesciences10-Q: Divestiture

Edwards Lifesciences finalizes divestiture of Critical Care unit to Becton Dickinson

What happened

The company is making post-sale working capital adjustments ($36.3M in the prior year) related to the sale, indicating the complexities of separating the business. This strategic shift to focus on core products creates needs for disentangling IT systems, financial reporting, and operational processes.

Source

SEC EDGARMay 6, 2026

Quarterly report (Form 10-Q)

Edwards Lifesciences 10-Q

Filing excerpt

Net cash provided by investing activities of $85.3 million for the three months ended March 31, 2025, consisted primarily of net proceeds from investments of $198.4 million, partially offset by capital expenditures of $56.0 million and a payment for a net working capital adjustment of $36.3 million related to the sale of Critical Care.

sec.gov/Archives/edgar/data/1099800/000109980026000026/ew-20260331.htmRead the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Divestiture

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
03/31
Filed
May 6, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$36.3M (Net working capital adjustment related to the sale of Critical Care in the prior year period)

Details

CIK
1099800
Accession number
0001099800-26-000026
Filing year
2026
Fiscal year
0
Why it matters
Carve-out support needed
Signal category
Strategic

Topics and mentions

Vendors

  • Becton
  • Dickinson and Company

Vendors named

  • Becton, Dickinson and Company

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
May 12, 2026
signal_type
sec-10q
signal_subtype
divestiture

Use this data

Get every 10-Q signal for Edwards Lifesciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Edwards Lifesciences this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/7876e7ba-2c53-4d22-add5-cbc8e1e119aa returns this record as JSON. POST /v1/companies/enrich returns every signal for edwards.com.

{
  "signal_id": "7876e7ba-2c53-4d22-add5-cbc8e1e119aa",
  "signal_type": "sec-10q",
  "signal_subtype": "divestiture",
  "detected_at": "2026-05-12T09:24:56.159+00:00",
  "company": {
    "name": "Edwards Lifesciences",
    "domain": "edwards.com"
  },
  "data": {
    "detail": "The company is making post-sale working capital adjustments ($36.3M in the prior year) related to the sale, indicating the complexities of separating the business. This strategic shift to focus on core products creates needs for disentangling IT systems, financial reporting, and operational processes.",
    "metrics": {
      "dollar_context": "Net working capital adjustment related to the sale of Critical Care in the prior year period",
      "dollar_millions": 36.3
    },
    "summary": "Edwards Lifesciences finalizes divestiture of Critical Care unit to Becton Dickinson",
    "excerpts": "Net cash provided by investing activities of $85.3 million for the three months ended March 31, 2025, consisted primarily of net proceeds from investments of $198.4 million, partially offset by capital expenditures of $56.0 million and a payment for a net working capital adjustment of $36.3 million related to the sale of Critical Care.",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1099800/000109980026000026/ew-20260331.htm",
    "filing_date": "2026-05-06",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Carve-out support needed",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Becton, Dickinson and Company"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.